Onconetix
ONCO
5 hedge funds and large institutions have $24.9K invested in Onconetix in 2026 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0% more funds holding
Funds holding: 5 → 5 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0.03% less ownership
Funds ownership: 0.08% → 0.05% (-0.03%)
74% less capital invested
Capital invested by funds: $95.3K → $24.9K (-$70.3K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$61.7K |
| 2 |
Citigroup
New York
|
+$8.96K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.68K |
| 4 |
SS
SBI Securities
Tokyo,
Japan
|
+$469 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
-$60.9K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$16.9K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.35K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$17 |
| 5 |
DB
Danske Bank
Copenhagen K,
Denmark
|
-$2 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $17.7K | +$61.7K | +1,185 | New |
|
|
2
Citigroup
New York
| $2.56K | +$8.96K | +172 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $2.35K | -$1.35K | -26 | -14% |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $2.17K | +$5.68K | +109 | +303% |
|
|
SS
5
SBI Securities
Tokyo,
Japan
| $179 | +$469 | +9 | +300% |
|
|
DS
6
DRW Securities
Chicago,
Illinois
| – | -$60.9K | -781 | Closed |
|
|
XT
7
XTX Topco
George Town,
Cayman Islands
| – | -$16.9K | -217 | Closed |
|
|
8
Bank of America
Charlotte,
North Carolina
| – | -$17 | – | – |
|
|
DB
9
Danske Bank
Copenhagen K,
Denmark
| – | -$2 | – | – |
|
ONCO Hedge Fund Activity: Q1 2026 in Review
5 of the 8,169 institutional investors tracked by Wall St. Rank reported a position in Onconetix (ONCO) for Q1 2026, worth a combined $24.9K — down 74% from $95.3K a quarter earlier.
Fund positioning in ONCO was balanced in Q1 2026: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $61.7K. The largest seller was DRW Securities, exiting entirely with an estimated $60.9K sold.
- 5 institutional investors held Onconetix (ONCO) as of Q1 2026, unchanged from Q4 2025.
- Funds reported $24.9K of Onconetix stock for Q1 2026, down 74% quarter-over-quarter.
- 2 funds opened new Onconetix positions in Q1 2026 and 2 closed out, a net change of 0 holders.
- The largest Onconetix buyer in Q1 2026 was Geode Capital Management, an estimated $61.7K added.
- The largest Onconetix seller in Q1 2026 was DRW Securities, an estimated $60.9K sold.
Based on aggregated 13F filings for Q1 2026.